Market Insights 

Healthcare research and the high demand for food are key areas where next-generation sequencing is being used extensively. Increasing genetic disorders are being diagnosed which has drastically increased the demand for next-generation sequencing. Moreover, the use of this technology in drug discovery is significant and expected to drive growth as the demand for effective drug therapies increases. 

Also known as massive parallel sequencing or high throughput sequencing technology, next-gen sequencing has been transformative for the field of genomic research as it allows the sequencing of a complete human genome in a very short amount of time. During the process, the genetic material is extracted, fragmented, and associated with various factors for amplification. As such, this technology is highly effective and advanced thus driving its adoption and growth. The improved speed and reduced costs are expected to drive market growth. Use in clinical applications, agricultural applications, and forensic applications are growing rapidly.

Increasing awareness, employment of various growth strategies and ongoing technical advancements are expected to provide the market with ample opportunity for growth. However, the high initial cost of implementing technologies, and the requirement for storage of large volumes of data as well as a lack of skilled workforce to run the technology are challenges to the growth of the Next Generation Sequencing market.


Key Players

Oxford Nanopore Technologies, Ltd., BGI, Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo Fisher Scientific, Inc. are among the notable market players that have been included in MRFR’s competition tracking of the global next generation sequencing market. 

Market Segmentation

Analysis of the markets several parts are included in MRFR's segmental analysis which has been performed on the basis of technology, service & product, application, end-user, and region. 

The technology used in next-generation sequencing includes whole exome sequencing, CHIP sequencing, whole genome sequencing, methyl sequencing, targeted resequencing, de novo sequencing, and RNA sequencing, next generation sequencing data analysis.

By service & product, the next generation sequencing market has been segmented into consumables, sample preparation, platforms & services for platforms, and sequencing services. The sample preparation segment is further divided into end repair, A-tailing & size selection, quality control, library preparation & target enrichment, and DNA fragmentation. Other sub-segmentations have been mentioned and expounded on in the report. 


Regional Analysis

The global next generation sequencing market is segmented into key regions which include the Americas, Asia Pacific, Europe, and the Middle East & Africa. North America in the Americas region is slated to lead the market with the largest share due to the high competition between market players in the region as well as the rising demand for next-gen sequencing in the healthcare sector of developed economies such as the US and Canada. Moreover, the presence of a significant healthcare sector in the region combined with growing investments in healthcare toward the development of therapies for chronic diseases will push growth during the forecast period. 

The European region has the second largest market due to the significant R&D activities that take place in the region with regards to various fields including healthcare. The presence of pioneering next-gen sequencing technology market players are expected to make an impact on the market. However, growth here is restrained due to regulations and fragmentation of the market across Europe.

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.